EMA Public Support for Mobilise-D: Follow-up

In the first year of Mobilise-D, we asked the European Medicines Agency (EMA) for Qualification Advice regarding Digital Mobility Outcomes (DMOs). EMA published their first letter of support in April 2020 that publicly endorsed our initial stage in the wider objective of the Mobilise-D consortium to pursue the qualification of Digital Mobility Outcomes (DMOs) as…

In the spotlight: Abolfazl Soltani’s Public PhD defense, Friday, Dec 11

This coming Friday Abolfazl Soltani, one of our Mobilisers from EPFL, Switzerland, will have the public defense of his PhD thesis.  In his PhD work, Abolfazl has focused on accurate walking speed estimation and walking bout detection based on wrist-worn sensors. Although there are many different digital systems that can monitor gait in unsupervised free-living situations such as housekeeping, catching a bus, and shopping, they each have different advantages and disadvantages.   One such system, the Global Navigation Satellite System (GNSS), can measure real-world gait speed accurately, but…

New publication: A roadmap to inform development, validation and approval of digital mobility outcomes: the Mobilise-D approach

Well known biomarkers such as blood pressure, respiration, temperature, pulse, and pain are frequently used by physicians and other health professionals to describe a patient’s health and disease status. In addition to these ‘signs of life’, there is another important aspect of people’s health and disease status, namely their mobility – how well they walk. Loss of physical mobility, such as reduced walking speed, is a significant feature of many health…